[Comparative efficacy of infliximab and adalimumab in patients with rheumatoid arthritis].

Autor: Tiurin VP, Mezenova TV, Iutrina TO, Usacheva IuV
Jazyk: ruština
Zdroj: Klinicheskaia meditsina [Klin Med (Mosk)] 2013; Vol. 91 (7), pp. 55-60.
Abstrakt: We compared the efficacy of recombinant infliximab and adalimumab in patients with severe and moderately severe rheumatoid arthritis. Infliximab produced rapid anti-inflammatory effect in the early period of therapy whereas adalimumab ensured more stable reduction of clinical and laboratory parameters of activity.
Databáze: MEDLINE